Gentel Biosciences Closes Shop; Assets Purchased by Intuitive Biosciences | GenomeWeb

NEW YORK (GenomeWeb News) – Intuitive Biosciences today announced an agreement to purchase the animal health and research tools assets and businesses of Gentel Biosciences for an undisclosed amount.

The deal is expected to close during the second quarter.

Gentel has been out of business since March 1, according to its website.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The Wall Street Journal reports that National Institutes of Health Director Francis Collins' response to contamination concerns at the agency might have delayed care.

The final revision of the Common Rule doesn't include the proposed change requiring consent for leftover biospecimens.

The first Reproducibility Project: Cancer Biology papers show mixed results.

In Nature this week: mobile phone-based targeted DNA sequencing, and more.